Correlation Between Dyadic International and Innate Pharma

Can any of the company-specific risk be diversified away by investing in both Dyadic International and Innate Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyadic International and Innate Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dyadic International and Innate Pharma, you can compare the effects of market volatilities on Dyadic International and Innate Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyadic International with a short position of Innate Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyadic International and Innate Pharma.

Diversification Opportunities for Dyadic International and Innate Pharma

0.02

Correlation Coefficient

Dyadic International  Innate Pharma

Significant diversification

The 3 months correlation between Dyadic and Innate is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Dyadic International and Innate Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innate Pharma and Dyadic International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyadic International are associated (or correlated) with Innate Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innate Pharma has no effect on the direction of Dyadic International i.e., Dyadic International and Innate Pharma go up and down completely randomly.

Pair Corralation between Dyadic International and Innate Pharma

Given the investment horizon of 90 days Dyadic International is expected to under-perform the Innate Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Dyadic International is 1.14 times less risky than Innate Pharma. The stock trades about -0.03 of its potential returns per unit of risk. The Innate Pharma is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  289.00  in Innate Pharma on June 16, 2024 and sell it today you would lose (63.00) from holding Innate Pharma or give up 21.8% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Dyadic International  vs.  Innate Pharma

Dyadic International

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Dyadic International has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in October 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Innate Pharma

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Innate Pharma are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating technical indicators, Innate Pharma may actually be approaching a critical reversion point that can send shares even higher in October 2024.

Pair Trading with Dyadic International and Innate Pharma

The main advantage of trading using opposite Dyadic International and Innate Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyadic International position performs unexpectedly, Innate Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innate Pharma will offset losses from the drop in Innate Pharma's long position.

The idea behind Dyadic International and Innate Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.